Patents

  • FTN: SC ruling on Novartis: Should cancer drugs be cheaply available? April 2, 2013

    In a landmark verdict, the Supreme Court of India dismissed a plea by the Swiss pharmaceutical giant Novartis on Monday for a patent on its cancer drug Glivec, paving way for more affordable life saving drug. ...
  • Novartis cannot ignore India's huge market: Indian Pharmaceutical Alliance April 1, 2013

    The secretary general of the Indian Pharmaceutical Alliance, DG Shah said that Novartis was merely posturing and it could not ignore the huge market that India provided to its products. ...
  • Patent case: Decision on legal recourse after reading SC judgement, says Novartis April 1, 2013

    The Supreme Court on Monday dismissed Swiss drugmaker Novartis's attempt to win patent protection for its cancer drug Glivec. ...
  • 'Has to be a balance between innovation, affordability of drugs' April 1, 2013

    After the Supreme Court dismissed Swiss pharma company Novartis' plea for a patent on its cancer drug Glivec, pharma expert vikas Dandekar said, "This will be a far reaching decision. Innovation on one side, access and affordability on the other side. The balance has to be done". ...
  • Cancer Patients Aid Association hails SC's verdict April 1, 2013

    In a landmark verdict, the Supreme Court of India dismissed a plea by the Swiss pharmaceutical giant Novartis on Monday for a patent on its cancer drug Glivec, paving way for more affordable life saving cancer drugs. "Generic companies will have a levy that will allow them to survive in...
  • Samsung to pay up $1 bn to Apple in patent case August 25, 2012

    The Korean company has been asked to pay Apple Inc over one billion dollars for copying critical features of the hugely popular iPhone and iPad. ...